2018 Catch-Up Vaccination Schedules: 4 Months-18 Years

Share this content:
2016 CATCH-UP VACCINATION SCHEDULE: 4 MONTHS−18 YEARS*
2018 CATCH-UP VACCINATION SCHEDULE: 4 MONTHS−18 YEARS*
Vaccine Minimum
Age for
Dose 1
Minimum Interval Between Doses
Dose 1 to Dose 2 Dose 2 to Dose 3 Dose 3 to Dose 4 Dose 4 to
Dose 5
Persons Aged 4 Months−6 Years
HepB1 Birth 4 weeks

8 weeks
and at least 16wks after 1st dose; minimum age for the final dose is 24wks



RV2 6 weeks maximum age 14wks, 6 days for 1st dose 4 weeks 4 weeks maximum age 8mos, 0 days for final dose

DTaP3 6 weeks 4 weeks 4 weeks 6 months 6 months3
Hib4 6 weeks

4 weeks
if 1st dose given before 1st birthday

8 weeks (as final dose)
if 1st dose given at age 12−14mos

No further doses needed
if 1st dose given at age ≥15mos

4 weeks4
if current age is <12mos and 1st dose was given at <7mos of age, and at least 1 previous dose was PRP-T (ActHib, Pentacel, Hiberix) or unknown

8 weeks and age 12−59mos (as final dose)4
if current age is <12mos and 1st dose was given at age 7−11mos; OR if current age is 12−59mos and 1st dose was given before 1st birthday, and 2nd dose given at <15mos of age; OR if both doses were PRP-OMP (PedvaxHIB; Comvax) and were given before 1st birthday

No further doses needed
if previous dose given at age ≥15mos

8 weeks (as final dose)
This dose only necessary for ages 12−59mos who received 3 doses before 1st birthday


PCV13, PPSV235 6 weeks

4 weeks
if 1st dose given before 1st birthday

8 weeks (as final dose for healthy children)
if 1st dose given at or after 1st birthday

No further doses needed
for healthy children if 1st dose given at age ≥24mos

4 weeks
if current age <12mos and previous dose given at age <7mos

8 weeks (as final dose for healthy children)
previous dose given between 7−11mos (wait until at least 12mos old); OR if current age is ≥12mos and at least 1 dose was given before age 12mos.

No further doses needed
for healthy children if previous dose given at age ≥24mos

8 weeks (as final dose)
This dose only necessary for ages 12−59mos who received 3 doses before age 12mos or for high-risk children who received 3 doses at any age


IPV6 6 weeks 4 weeks6 4 weeks6 if person is <4yrs
6 months (as final dose) if person is ≥4yrs

6 months6
minimum age 4yrs for final dose


MMR8 12mos 4 weeks


VAR9 12mos 3 months


HepA10 12mos 6 months


Meningococcal11 6 weeks 8 weeks11 see footnote 11 see footnote 11
Persons Aged 7−18 Years
Meningococcal11 N/A 8 weeks11


Td/Tdap12 7 years12 4 weeks

4 weeks
if 1st dose of DTaP/DT given before 1st birthday

6 months (as final dose)
if 1st dose of DTaP/DT or Tdap/Td given at or after 1st birthday

6 months
if 1st dose of DTaP/DT given before 1st birthday


HPV13 9 years Routine dosing intervals are recommended13
HepA10 N/A 6 months      
HepB1 N/A 4 weeks

8 weeks
and at least 16wks after 1st dose



IPV6 N/A 4 weeks 6 months6 A 4th dose is not necessary if 3rd dose given at age ≥4yrs and ≥6mos after previous dose A 4th dose is indicated if all previous doses were given at age <4yrs or if 3rd dose given <6mos after 2nd dose
MMR8 N/A 4 weeks


VAR9 N/A

3 months
if person is <13yrs

4 weeks
if person is ≥13yrs




Footnotes to 2018 CATCH-UP VACCINATION SCHEDULES: 4 MONTHS−18 YEARS OF AGE

*The tables provide catch‑up schedules and minimum intervals between doses for children whose vaccinations have been delayed. A vaccine series does not need to be restarted, regardless of the time that has elapsed between doses. Use the section appropriate for the child's age. Always use this table in conjunction with the child and adolescent immunization schedules (“Vaccination Schedule: 0−18 Years of Age”) and their respective footnotes.

1. Hepatitis B (HepB) vaccine. (Minimum age: birth)

• Unvaccinated persons should complete a 3‑dose series.

• A 2‑dose series (doses separated by at least 4mos) of adult formulation Recombivax HB may be given to children aged 11−15yrs.

2. Rotavirus (RV) vaccines (Minimum age: 6wks for both RV1 [Rotarix] and RV5 [RotaTeq]).

• Vaccination series should not be initiated at age 15wks, 0 days or older.

• Administer a 2-dose series (Rotarix) or a 3-dose series (Rotateq). If any dose in the series is either Rotateq or unknown, default to a 3-dose series.

3. Diphtheria, tetanus, and acellular pertussis (DTaP) vaccine. (Minimum age: 6wks. Exception: DTaP‑IPV [Kinrix, Quadracel]: 4yrs)

• The 5th dose of DTaP vaccine is not necessary if the 4th dose was given at age ≥4yrs.

4. Haemophilus influenzae type b (Hib) conjugate vaccine. (Minimum age: 6wks for PRP‑T [ACTHIB, DTaP‑IPV/Hib (Pentacel), Hiberix], PRP‑OMP [PedvaxHIB])

• If the 1st dose was given at age 7−11mos, give the 2nd dose at least 4wks later and a 3rd (and final) dose at age 12−15mos or 8wks after 2nd dose, whichever is later.

• If 1st dose was given at ages 12−14mos, give 2nd (final) dose at least 8wks after dose 1.

• If first dose is given before 1st birthday and 2nd dose is given <15mos of age, a 3rd (and final) dose should be given 8wks after 2nd dose.

• If 2 doses of PedvaxHIB were given before 1st birthday, the 3rd (and final) dose should be given at age 12−59mos and at least 8wks after the 2nd dose.

• For unvaccinated children aged 15–59mos, give only 1 dose.

5. Pneumococcal vaccines. (Minimum age: 6wks for PCV13, 2yrs for PPSV23)

• Administer 1 dose of PCV13 to all healthy children aged 24−59mos who are not completely vaccinated for their age.

6. Inactivated poliovirus vaccine (IPV). (Minimum age: 6wks)

• In the first 6mos of life, minimum age and minimum intervals are only recommended if the person is at risk for imminent exposure to circulating poliovirus (eg, travel to a polio-endemic region or during an outbreak).

• If ≥4 doses are given before age 4yrs, an additional dose should be given at age 4−6yrs and at least 6mos after the previous dose.

• A 4th dose is not necessary if the 3rd dose was given at age ≥4yrs and at least 6mos after the previous dose.

• If both OPV (trivalent) and IPV were given as part of a series, a total of 4 doses should be given to complete the series. Doses should be at least 4wks apart, with the final dose given on or after the 4th birthday and at least 6mos after the previous dose. If only OPV were given, and all doses given before 4yrs of age, 1 dose of IPV should be given at age ≥4yrs, at least 6mos after last OPV dose.

• IPV is not routinely recommended for U.S. residents aged ≥18yrs.

7. Influenza vaccines. (Minimum age: 6mos for inactivated influenza vaccine [IIV]; 18yrs for recombinant influenza vaccine [RIV]).

• See “VACCINATION SCHEDULE: 0−18 YEARS OF AGE” for further guidance.

8. Measles, mumps, and rubella (MMR) vaccine. (Minimum age: 12mos for routine vaccination)

• Unvaccinated persons should complete a 2-dose series at least 4wks apart.

9. Varicella (VAR) vaccine. (Minimum age: 12mos)

• Ensure that all persons aged 7−18yrs without evidence of immunity have 2 doses of varicella vaccine. For children aged 7−12yrs, the recommended interval between doses is 3mos (if the 2nd dose was given at least 4wks after the 1st dose, it can be accepted as valid); for persons aged ≥13yrs, the minimum interval between doses is 4wks.

10. Hepatitis A vaccine (HepA). (Minimum age: 12mos)

• Any person ≥2yrs may receive vaccine if desired, at least 6mos apart.

11. Meningococcal vaccines. (Minimum age: 9mos for MenACWY-D [Menactra], 2mos for MenACWY-CRM [Menveo], 10yrs for serogroup B meningococcal [MenB] vaccines: MenB-4C [Bexsero] and MenB-FHbp [Trumenba])

• Give Menactra or Menveo vaccine at age 13−18yrs if not previously vaccinated.

• If the 1st dose is given at age 13−15yrs, a booster dose should be given at age 16−18yrs with a minimum interval of at least 8wks between doses.

• If the 1st dose is given at age ≥16yrs, a booster dose is not needed.

• MenB vaccines: a 2-dose series may be given at clinical discretion to persons 16−23yrs (16−18 preferred) who are not at increased risk.

12. Tetanus, diphtheria, and acellular pertussis (Tdap) vaccine. (Minimum age: 11yrs for routine vaccination, 7yrs for catch-up).

• Persons 13−18yrs who have not received Tdap vaccine should receive 1 dose of Tdap followed by Td booster every 10yrs.

• Persons 7−18yrs not fully immunized with DTaP should receive 1 dose of Tdap as part of the catch-up series (preferably 1st dose). Give Td if more doses are needed.

• Children 7−10yrs who received Tdap inadvertently or as part of the catch-up series may receive routine Tdap dose at age 11−12yrs.

• Inadvertent doses of DTaP vaccine:

− If administered inadvertently at age 7–10yrs, DTaP may count as part of the catch‑up series. Routine Tdap dose may be given at age 11−12yrs.

− If administered inadvertently at age 11−18yrs, the dose should be counted as the adolescent Tdap booster.

13. Human papillomavirus (HPV) vaccines. (Minimum age: 9yrs for 4vHPV [Gardasil] and 9vHPV [Gardasil 9])

• Give HPV vaccine to all adolescents through age 18yrs who were not previously adequately vaccinated.

• Give 2 doses at 0, 6−12mos if initiating vaccination at age 9−14yrs. Minimum interval between 1st and 2nd dose is 5mos. If 2nd dose given too soon, a 3rd dose should be given a minimum of 12wks after 2nd dose and minimum of 5mos after 1st dose.

• Give 3 doses at 0, 1−2, 6mos if initiating vaccination at age ≥15yrs. Minimum intervals are 4wks between 1st and 2nd dose, 12wks between 2nd and 3rd dose, and 5mos between 1st and 3rd dose. If dose given too soon, it should be readministered after another minimum interval has been met since the most recent dose.

CHANGES IN THE SCHEDULE SINCE LAST RELEASE

• The maximum ages for the 1st and last doses of rotavirus series have been added to the rotavirus vaccine row.

• The IPV rows have been updated to clarify catch-up recommendations for children ≥4yrs.

REFERENCES

For information on individual vaccines see product monographs, contact the manufacturer, or call the National Immunization Hotline at (800) 232-4636. Source: Advisory Committee on Immunization Practices (ACIP). Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger— United States, 2018. http://www.cdc.gov/vaccines/schedules/hcp/imz/catchup.html

(Rev. 3/2018)

You must be a registered member of Infectious Disease Advisor to post a comment.

Sign Up for Free e-newsletters